// STATE LEGISLATION TRACKER

Massachusetts H355: An Act relative to animal telehealth

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Massachusetts
Bill: H355
Session: 194th
Filed: 2025-02-27
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Massachusetts H355 is about veterinary telehealth for animal patients, not human health care. Based on its title, text, and latest action, it does not affect compounded peptides, off-label prescribing, human telehealth, NP or naturopath scope, FDA 503A/503B compounding, controlled substances access, or prescription monitoring for peptide users.

Key Points

No direct effect on human peptide prescribing or access
Applies to veterinarians and animal patients, not peptide clinics
Does not change NP, naturopath, or telehealth clinician scope
Does not address FDA 503A or 503B compounding rules
No peptide-specific controlled substance or PDMP changes

What to Watch For

Note Animal telehealth rules can sometimes influence broader telehealth policy debates, but this bill is veterinary-only.

Note The bill was sent to a study order, which usually means it is not moving as a standalone bill.

Where the Bill Stands

The latest action was referral into a study order, H5081, so H355 is not advancing on its own.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws